Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STON1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | ORMDL2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | PLEKHH1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
mRNA | POLR2L | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | AKAP9 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | CTDSPL2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | RRAS2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
mRNA | STRADB | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | CD48 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
mRNA | FCRL4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |